HomeCancerColorectal Key Findings from the INTERCEPT Examine – Most cancers Community Colorectal July 9, 2024 66 0 Purposeful Precision Drugs: The New Precision Oncology? August 6, 2026 The Story of Immune Checkpoint Inhibitors and Immunotherapy July 21, 2026 Reflections on Progress at ASCO 2026 June 23, 2026 NCI’s Message and High Priorities June 16, 2026 NCI’s Message and High Priorities May 4, 2026 Key Findings from the INTERCEPT Examine Most cancers Community Share FacebookTwitterPinterestWhatsApp Previous articleScientists spotlight distinctive lung most cancers traits in Southeast Asia, name for region-centric analysisNext articleNavigating Most cancers as a Caretaker, Nurse, and Affected person Hot Topics Purposeful Precision Drugs: The New Precision Oncology? The Story of Immune Checkpoint Inhibitors and Immunotherapy Reflections on Progress at ASCO 2026 Load more Related Articles Editor - August 6, 2026Purposeful Precision Drugs: The New Precision Oncology? Editor - July 21, 2026The Story of Immune Checkpoint Inhibitors and Immunotherapy Editor - June 23, 2026Reflections on Progress at ASCO 2026 Load more
